• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

CellaVision AB (CEVI)

Sell: 203.00 SEK|Buy: 204.00 SEK|Change: 4.40 (2.23%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

Address




Website

https://www.cellavision.com

Sector 

Healthcare

Forecast key dates

NameKey Date
CellaVision AB Annual General Meeting for 20262026-05-06T00:00:00
CellaVision AB First Quarter Earnings Conference Call for 20262026-04-29T11:00:00
CellaVision AB First Quarter Earnings Results for 20262026-04-29T07:20:00
CellaVision AB Annual Report for 20252026-04-10T00:00:00
CellaVision AB Fourth Quarter Earnings Result for 20252026-02-05T00:00:00
CellaVision AB Fourth Quarter Earnings Conference Call for 20252026-02-05T00:00:00
CellaVision AB Third Quarter Earnings Result for 20252025-11-06T00:00:00
CellaVision AB Third Quarter Earnings Conference Call for 20252025-11-06T00:00:00
CellaVision AB Second Quarter Earnings Result for 20252025-07-18T00:00:00
CellaVision AB Second Quarter Earnings Conference Call for 20252025-07-18T00:00:00
CellaVision AB Annual General Meeting for 20252025-05-06T00:00:00

Previous key dates

NameKey Date
CellaVision AB Annual General Meeting for 20252025-05-06T00:00:00
CellaVision AB First Quarter Earnings Conference Call for 20252025-04-29T11:00:00
CellaVision AB First Quarter Earnings Results for 20252025-04-29T07:20:00
CellaVision AB Annual Report for 20242025-04-10T00:00:00
CellaVision AB Fourth Quarter Earnings Conference Call for 20242025-02-06T11:00:00
CellaVision AB Fourth Quarter Earnings Results for 20242025-02-06T07:20:00
CellaVision AB Third Quarter Earnings Conference Call for 20242024-10-24T11:00:00
CellaVision AB Third Quarter Earnings Results for 20242024-10-24T07:20:00
CellaVision AB Second Quarter Earnings Conference Call for 20242024-07-19T11:00:00
CellaVision AB Second Quarter Earnings Results for 20242024-07-19T07:20:00
CellaVision AB Annual General Meeting for 20242024-05-03T15:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.